SMTL ID : 5ln2.1

Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.58 Å

Oligo State

monomer

Ligands

1 x 6ZT: (4~{S})-5-[5-chloranyl-2-[2-(dimethylamino)ethoxy]phenyl]-4-(4-chloranyl-2-methyl-phenyl)-2-(2-methoxyphenyl)-3-propan-2-yl-4~{H}-pyrrolo[3,4-c]pyrazol-6-one(Non-covalent)

6ZT.1: 13 residues within 4Å: Chain A: L.39, L.42, G.43, I.46, M.47, Y.52, Q.57, V.60, F.71, V.78, H.81, I.84, Y.85 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.39, A:L.39, A:L.39, A:I.46, A:V.78 pi-Stacking: A:H.81 Halogen bonds: A:H.81

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: S.2, Q.3, I.4, H.81 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:S.2, A:Q.3, A:Q.3, A:I.4, A:I.4 Water bridges: A:H.81, A:H.81 Salt bridges: A:H.81

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 3 residues within 4Å: Chain A: K.49, D.65, L.66 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Furet, P. et al., Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument. Bioorg.Med.Chem.Lett. (2016)

Release Date

2016-09-07

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence